• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer

BerGenBio

Selective AXL inhibitors

Header Right

Main navigation

  • About BerGenBio
    • About BerGenBio
    • Management Team
    • Board of Directors
    • Partners
  • Pipeline
    • Pipeline overview
    • bemcentinib | NSCLC
    • bemcentinib | TNBC
    • bemcentinib | Melanoma
    • bemcentinib | AML
    • BGB149
    • BGB601
    • Discovery
    • Publications
  • Media Centre
    • News
    • Events
    • Media Contacts
  • Investors
    • Share Information
    • Largest Shareholders
    • Stock Exchange Notices
    • Presentations
    • Financial Reports
    • Financial Calendar
    • Analysts
    • General Meetings
    • Corporate Governance
    • IR Contacts
  • Contact
Home  /  Investors  /  Financial Calendar

Financial Calendar

Financial Year 2019

 

12 February 2019
Quarterly Report – Q4 2018
20 February 2019
Annual report 2018
13 March 2019
Annual General Meeting
8 May 2019
Quarterly Report – Q1 2019
20 August 2019
Half-year report 2019
19 November
Quarterly Report – Q3 2019
19 November
Quarterly Report – Q3 2019
The dates are subject to change. The time and location of the presentations will be announced in due time.

Primary Sidebar

  • Investors
    • Share Information
    • Largest Shareholders
    • Stock Exchange Notices
    • Presentations
    • Financial Reports
    • Financial Calendar
    • Analysts
    • General Meetings
    • Corporate Governance
    • IR Contacts

News Subscription

Please remember to confirm your email by clicking on the link provided in the subscription confirmation email.

We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.

Footer

Key Information

  • Pipeline
  • Investors
  • News
  • Presentations
  • Management Team

Useful Information

  • Privacy Policy
  • Terms of Use
  • Site Map

Get In Touch

BerGenBio ASA
Company registration number 992 219 688

Jonas Lies vei 91, 5009 Bergen, Norway

www.bergenbio.com

+ 47 559 61 159 (general) + 47 535 01 564 (urgent medical enquiries)

Copyright © 2017 BerGenBio ASA. All right reserved. Designed by Utopian Designs